Shaheer Bardissi

Dr. Shaheer Bardissi serves as Co-CEO and Executive Board Member at Minapharm Pharmaceuticals, an Egyptian biopharmaceutical company with multiple global subsidiaries. Shaheer is responsible for the growth strategy of the Minapharm group in the field of immuno-oncology, vaccines, and cell and gene-based therapies in collaboration with its global subsidiaries, as well as Minapharm’s biological portfolio expansion throughout the African continent. He is also in the supervisory and advisory boards of several biotech companies. Shaheer previously worked at BioNTech and contributed to the successful development of immunotherapeutic technologies in the field of cell and gene therapy. Shaheer obtained his PhD from Johannes Gutenberg University, Mainz, Germany, with a focus on gene-based immunotherapy. Prior to that, he completed his Masters of Science in Molecular Medicine at University College London, Bachelors of Science in Biomedical Sciences from King's college London, and also holds a Master’s of Science in quantitative management sciences and healthcare data analytics from Duke University, North Carolina, USA